Loading…
bwge2017 has ended

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Type: BASL Meeting, SESSION 3 [clear filter]
Thursday, February 9
 

13:15 CET

Satellite Symposium BMS Room LIJN 3rd floor

14:00 CET

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): establishment of a unique, innovating animal model with insufficient liver remnant. Room LIJN 3rd floorALEXANDRA DILI

14:12 CET

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience. Room LIJN 3rd floorRob Bielen

14:24 CET

Pegylated interferon alpha treatment rapidly clears Hepatitis E Virus infections in humanized mice. Room LIJN 3rd floorThomas VANWOLLEGHEM

14:36 CET

Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation Room LIJN 3rd floorRob Bielen

14:48 CET

PPARα-regulated dermatopontin is an important contributor to the liver fibrotic response in mouse models and has relevance to fibrosis progression in NAFLD patients. Room LIJN 3rd floorPHILIPPE LEFEBVRE

15:00 CET

MARC HAUTEKEETE LECTURE : Do direct antiviral agents for HCV increase risk of hepatocellular carcinoma : fact, fiction or undecided? Room LIJN 3rd floorMarc Hautekeete